CVA Family Office’s Moleculin Biotech MBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10 | Hold |
34
| – | – | ﹤0.01% | 1279 |
|
|
2025
Q1 | $33 | Hold |
34
| – | – | ﹤0.01% | 1385 |
|
|
2024
Q4 | $58 | Hold |
34
| – | – | ﹤0.01% | 1281 |
|
|
2024
Q3 | $97 | Hold |
34
| – | – | ﹤0.01% | 1259 |
|
|
2024
Q2 | $120 | Hold |
34
| – | – | ﹤0.01% | 1264 |
|
|
2024
Q1 | $201 | Buy |
34
+1
| +3% | +$6 | ﹤0.01% | 1044 |
|
|
2023
Q4 | $429 | Buy |
+33
| New | +$429 | ﹤0.01% | 1020 |
|
|
2023
Q3 | – | Sell |
-33
| Closed | -$289 | – | 657 |
|
|
2023
Q2 | $289 | Hold |
33
| – | – | ﹤0.01% | 995 |
|
|
2023
Q1 | $480 | Hold |
33
| – | – | ﹤0.01% | 942 |
|
|
2022
Q4 | $530 | Hold |
33
| – | – | ﹤0.01% | 896 |
|
|
2022
Q3 | $1K | Hold |
33
| – | – | ﹤0.01% | 852 |
|
|
2022
Q2 | $1K | Hold |
33
| – | – | ﹤0.01% | 875 |
|
|
2022
Q1 | $1K | Hold |
33
| – | – | ﹤0.01% | 927 |
|
|
2021
Q4 | $1K | Buy |
+33
| New | +$1K | ﹤0.01% | 880 |
|
|
2021
Q3 | – | Sell |
-33
| Closed | -$2K | – | 658 |
|
|
2021
Q2 | $2K | Hold |
33
| – | – | ﹤0.01% | 887 |
|
|
2021
Q1 | $2K | Buy |
+33
| New | +$2K | ﹤0.01% | 708 |
|